Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 3.4.16.2 extracted from

  • Qin, X.; Zeng, S.; Tian, H.; Deng, S.; Ren, J.; Zheng, Y.; Li, D.; Li, Y.; Liao, D.; Chen, S.
    Involvement of prolylcarboxypeptidase in the effect of rutaecarpine on the regression of mesenteric artery hypertrophy in renovascular hypertensive rats (2009), Clin. Exp. Pharmacol. Physiol., 36, 319-324.
    View publication on PubMedView publication on EuropePMC
Search for more literature for 3.4.16.2

Organism

Organism UniProt Comment Textmining
Rattus norvegicus D4AA31
-
-

Source Tissue

Source Tissue Comment Organism Textmining
kidney expression of PRCP protein or kallikrein mRNA expression is significantly inhibited in the right kidneys and mesenteric arteries of hypertensive rats. Expression is significantly increased after treatment with rutaecarpine or lorsartan Rattus norvegicus
-
mesenteric artery expression of PRCP protein or kallikrein mRNA expression is significantly inhibited in the right kidneys and mesenteric arteries of hypertensive rats. Expression is significantly increased after treatment with rutaecarpine or lorsartan Rattus norvegicus
-

Synonyms

Synonyms Comment Organism
PRCP
-
 Rattus norvegicus
prolylcarboxypeptidase
-
 Rattus norvegicus

Expression

Organism Comment Expression
Rattus norvegicus expression of PRCP protein or kallikrein mRNA expression is significantly inhibited in the right kidneys and mesenteric arteries of hypertensive rats down
Rattus norvegicus expression of PRC is significantly increased in the right kidneys and mesenteric arteries of hypertensive rats after treatment with rutaecarpine or lorsartan up